Your browser doesn't support javascript.
loading
Small molecule induced STING degradation facilitated by the HECT ligase HERC4.
Mutlu, Merve; Schmidt, Isabel; Morrison, Andrew I; Goretzki, Benedikt; Freuler, Felix; Begue, Damien; Simic, Oliver; Pythoud, Nicolas; Ahrne, Erik; Kapps, Sandra; Roest, Susan; Bonenfant, Debora; Jeanpierre, Delphine; Tran, Thi-Thanh-Thao; Maher, Rob; An, Shaojian; Rietsch, Amandine; Nigsch, Florian; Hofmann, Andreas; Reece-Hoyes, John; Parker, Christian N; Guerini, Danilo.
Afiliación
  • Mutlu M; Novartis BioMedical Research, Basel, Switzerland. merve.koch@novartis.com.
  • Schmidt I; Novartis BioMedical Research, Basel, Switzerland.
  • Morrison AI; Novartis BioMedical Research, Basel, Switzerland.
  • Goretzki B; Amsterdam UMC location Vrije Universiteit Amsterdam, Molecular Cell Biology & Immunology, Amsterdam institute for Infection and Immunity, De Boelelaan, 1117, Amsterdam, The Netherlands.
  • Freuler F; Novartis BioMedical Research, Basel, Switzerland.
  • Begue D; Novartis BioMedical Research, Basel, Switzerland.
  • Simic O; Novartis BioMedical Research, Basel, Switzerland.
  • Pythoud N; Novartis BioMedical Research, Basel, Switzerland.
  • Ahrne E; Novartis BioMedical Research, Basel, Switzerland.
  • Kapps S; Novartis BioMedical Research, Basel, Switzerland.
  • Roest S; Novartis BioMedical Research, Basel, Switzerland.
  • Bonenfant D; Novartis BioMedical Research, Basel, Switzerland.
  • Jeanpierre D; Novartis BioMedical Research, Basel, Switzerland.
  • Tran TT; Monte Rosa Therapeutics, Basel, Switzerland.
  • Maher R; Novartis BioMedical Research, Basel, Switzerland.
  • An S; Novartis BioMedical Research, Basel, Switzerland.
  • Rietsch A; Novartis BioMedical Research, Cambridge, MA, USA.
  • Nigsch F; Novartis BioMedical Research, Cambridge, MA, USA.
  • Hofmann A; Novartis BioMedical Research, Basel, Switzerland.
  • Reece-Hoyes J; Novartis BioMedical Research, Basel, Switzerland.
  • Parker CN; Novartis BioMedical Research, Basel, Switzerland.
  • Guerini D; Novartis BioMedical Research, Cambridge, MA, USA.
Nat Commun ; 15(1): 4584, 2024 May 29.
Article en En | MEDLINE | ID: mdl-38811577
ABSTRACT
Stimulator of interferon genes (STING) is a central component of the cytosolic nucleic acids sensing pathway and as such master regulator of the type I interferon response. Due to its critical role in physiology and its' involvement in a variety of diseases, STING has been a focus for drug discovery. Targeted protein degradation (TPD) has emerged as a promising pharmacology for targeting previously considered undruggable proteins by hijacking the cellular ubiquitin proteasome system (UPS) with small molecules. Here, we identify AK59 as a STING degrader leveraging HERC4, a HECT-domain E3 ligase. Additionally, our data reveals that AK59 is effective on the common pathological STING mutations, suggesting a potential clinical application of this mechanism. Thus, these findings introduce HERC4 to the fields of TPD and of compound-induced degradation of STING, suggesting potential therapeutic applications.
Asunto(s)

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Ubiquitina-Proteína Ligasas / Proteolisis / Proteínas de la Membrana Idioma: En Revista: Nat Commun / Nature communications Asunto de la revista: BIOLOGIA / CIENCIA Año: 2024 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Ubiquitina-Proteína Ligasas / Proteolisis / Proteínas de la Membrana Idioma: En Revista: Nat Commun / Nature communications Asunto de la revista: BIOLOGIA / CIENCIA Año: 2024 Tipo del documento: Article